Urology Northwest offers PROVENGE® treatments

PROVENGEProstate cancer is the most common non-skin cancer in men in the United States, and the second leading cause of cancer death in men.

Urology Northwest is the first urology office in Washington to offer prostate cancer patients one of the latest advances in treatment options, the first-in-class immunotherapy, PROVENGE® (sipuleucel‑T).

For the full story, click here.

And be sure to read the Indication and Important Safety Information here.